pharma · Apnea of Prematurity · Safety and Pharmacokinetics
BELPHARMA
Belpharma s.a.
Belpharma is a pharma organization headquartered in LUXEMBOURG, LU. Primary therapeutic focus areas include Apnea of Prematurity, Safety and Pharmacokinetics. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s)
Luxembourg, LU HQ
2011 Founded
16 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Luxembourg, LU
- Founded
- 2011
- Employees
- 16
- Programs
- 3
- Drugs
- 2
- Patents
- 0
NPC-22
Phase 1 · small molecule · Healthy Adult Subjects
NPC-22 for Healthy Adult Subjects is a Phase 1 program (small_molecule) at Belpharma s.a. with 1 ClinicalTrials.gov record(s).
Internal code NPC-22
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Belpharma s.a.
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Healthy Adult Subjects
- Status
- completed
- Trials
- 1